Cellectis soon to close Cellartis buy with €50m fundraising
This article was originally published in Clinica
Executive Summary
French biotech firm Cellectis is a step closer to acquiring Swedish stem cell specialist Cellartis, after shareholders endorsed the takeover and gave their approval for a €50m ($69.7m) fundraising round to finance the deal.